References
Scheven E, Bakkaloglu A (2009) What’s new in paediatric SLE? Best Pract Res Clin Rheumatol 23:699–708
Yu F, Haas M, Glassock R, Zhao MH (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 13:483–495
Wen YK, Chen ML (2010) Clinicopathological study of originally non-lupus “full-house” nephropathy. Ren Fail 32:1025–1030
Aringer M, Costenbader K, Daikh D, Brinks R et al (2019) 2019 EULAR/ACR classification criteria for systemic lupus erythematosus. Arthritis Rheum 71:1400–1412
Gunay-Aygun M (2009) Liver and kidney disease in ciliopathies. Am J Med Genet C: Semin Med Genet 151C:296–306
Wen J (2011) Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease. Clin Transl Sci 4:460–465
Parmar K, Rathi S, Khanna A, Gupta M, Singh A, Singh SK, Singh V (2018) Portal hypertensive vesiculopathy: a rare cause of hematuria and a unique management strategy. Urology 115:e7–e8
Dołowy J, Stoinska A, Kuśmierska M, Kuniej T, Plucińska I, Jaźwiec P (2011) A case of a spontaneous splenorenal shunt associated with the nutcracker syndrome. Pol J Radiol 76:49–51
Simonetto DA, Gines P, Kamath PS (2020) Hepatorenal syndrome: pathophysiology, diagnosis, and management. BMJ 370:2687
Qi X, He C, Han G, Yin Z, Wu F, Zhang Q, Niu J, Wu K, Fan D (2013) Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 28:148–152
Saha MK, Julian BA, Novak J, Rizk DV (2018) Secondary IgA nephropathy. Kidney Int 94:674–681
Hommos MS, El-Zoghby ZM (2017) Renal outcomes in patients with IgA nephropathy undergoing liver transplant: a retrospective cohort study. Transplant Direct 11:e193
Kalambokis G, Christou L, Stefanou D, Arkoumani E, Tsianos EV (2007) Association of liver cirrhosis is related IgA nephropathy with portal hypertension. World J Gastroenterol 13:5783–5786
Nakamura M, Ohishi A, Watanabe R, Kaneko K, Aosaki N, Iigaya T et al (1994) IgA nephropathy associated with portal hypertension in liver cirrhosis due to non-alcoholic and non-A, non-B, non-C hepatitis. Intern Med 33:488–491
Babbs C, Warnes TW, Torrance HB, Ballardie FW (1991) IgA nephropathy in non-cirrhotic portal hypertension. Gut 32:225–226
Horn RC Jr, Smetana H (1942) Intercapillary glomerulosclerosis. Am J Pathol 18:93–99
Dash SC, Bhuyan UN, Dinda AK, Saxena S, Agarwal SK, Tiwari SC, Nundy S (1997) Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis. Kidney Int 52:482–485
Alghamdi SA, Saadah OI, Almatury N, Al-Maghrabi J (2012) Hepatic-associated immunoglobulin-A nephropathy in a child with liver cirrhosis and portal hypertension. Saudi J Gastroenterol 18:214–216
Singhal J, Sharma J (2018) IgA nephropathy secondary to liver disease. Pediatr Nephrol 33:2393
Nasri H, Mubarak M (2014) Comment on “Hepatic-associated immunoglobulin a nephropathy in a child with liver cirrhosis and portal hypertension”. Saudi J Gastroenterol 20:202
Macpherson AJ (2006) IgA adaptation to the presence of commensal bacteria in the intestine. Curr Top Microbiol Immunol 308:117–136
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at https://doi.org/10.1007/s00467-021-05161-1
Rights and permissions
About this article
Cite this article
Leventoğlu, E., Büyükkaragöz, B., Kenan, B.U. et al. Macroscopic hematuria in a child with portal hypertension: Answers. Pediatr Nephrol 36, 4037–4040 (2021). https://doi.org/10.1007/s00467-021-05186-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-021-05186-6